Baylor Genetics Recognized for Healthcare Industry Leadership and Innovation

Houston, Texas, March 12, 2024 – Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, has been recognized with several industry awards for leadership, excellence, and innovation in healthcare, biotech and life sciences.

Most recently, Kengo Takishima, president and Chief Executive Officer of Baylor Genetics, was cited for driving transformative change, delivering tangible results in 2023, and contributing to the future of healthcare by Life Sciences Voice, a leading source of news and insights for the life sciences industry.  He previously was selected among the Top 25 Health Technology Leaders in Houston and Slice of Healthcare’s 50 Under 50 list of top industry innovators.

Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer of Baylor Genetics has been recognized by Modern Healthcare as one of their Top Women leaders as part of its annual list published in the March 2024 issue of the magazine. She was recognized for spearheading enhancements to Baylor Genetics’ rapid Whole Genome Sequencing (WGS), Carrier Screening, Chromosomal Microarray Analysis, and Hereditary Cancer tests as well as several newly launched panels in 2023.  Dr. Eng also recently was elected to the Board of Directors for the American Society of Human Genetics (ASHG).

“Our focus is on putting patients, providers and partners first in all we do, working to streamline the diagnostic odyssey while ensuring high-quality, accurate genetic testing,” said Takishima. “This recent third-party recognition is a reflection of the dedicated efforts of hundreds of Baylor Genetics team members across our company who are committed to the highest standards of excellence and continuous learning.”

About Baylor Genetics

A pioneer of precision medicine for over 45 years, Baylor Genetics is a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels. A joint venture of H.U. Group Holdings, Inc. and Baylor College of Medicine, which has the #1 NIH-funded Department of Molecular and Human Genetics, Baylor Genetics couples the fastest and most comprehensive precision diagnostics options with the support of genetic counselors to help clinicians and their patients avoid a lengthy diagnostic odyssey, guide medical management, and make sure no patient with a genetic disorder gets left behind. Its test menu spans from family planning, pregnancy, neonatal and pediatric testing, oncology, and specialized test options. Baylor Genetics is located in Houston’s Texas Medical Center and serves clients in 50 states and 16 countries.

PR Contact
Maggie Naples
SVM Public Relations
(401) 490-9700

For more information on the products and/or services mentioned…

Previous Post
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024
Next Post
Baylor Genetics Prepares for a ‘Genome World’ With Explainable AI-Powered Variant Interpretation